Magnolia Medical Technologies

Magnolia Medical Technologies patented initial specimen diversion for blood culture collection, both the technique, ISDT®, and the technology, Initial Specimen Diversion Device®(ISDD®). Our mission: Enhance diagnostic accuracy and timeliness for sepsis testing to achieve better outcomes for all patients, reduce hospital costs, and battle the global threat of antibiotic resistance.